Cell and gene therapy with reporter gene imaging in myocardial ischemia.
CONCLUSION: This study confirmed that hERL/18F-FES could be used as a reporter gene/probe system for monitoring gene and cell therapy in the ischemic heart disease.
PMID: 29177255 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Adenoviruses | Cardiology | Estradiol | Gene Therapy | Genetics | Heart | Heart Attack | Heart Disease | Heart Transplant | Nuclear Medicine | Stem Cell Therapy | Stem Cells | Study | Transplants